Abstract: . . .  spective 4.5-year study. J Am Coll Cardiol 1995;25:1354-61. 50. Van Gelder IC, Crijns HJ, Van Gilst WH, Verwer R, Lie KI. Predic- tion of uneventful cardioversion and maintenance of sinus rhythm from di- rect-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol 1991;68:41-6. 51. Laupacis A, Boysen G, Connolly S, et al. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation : analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154: 1449-57. [Erratum, Arch Intern Med 1994;154:2254.] 52. Hart RG, Pearce LA, Rothbart RM, McAnulty JH, Asinger RW, Hal- perin JL. Stroke with intermittent atrial fibrillation : incidence and predic- tors during aspirin therapy. J Am Coll Cardiol 2000;35:183-7. 53. Cobbe SM, Rae AP, Poloniecki JD, et al. A randomized, placebo-con-  . . .
. . .  4.5-year study. J Am Coll Cardiol 1995;25:1354-61. 50. Van Gelder IC, Crijns HJ, Van Gilst WH, Verwer R, Lie KI. Predic- tion of uneventful cardioversion and maintenance of sinus rhythm from di- rect-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol 1991;68:41-6. 51. Laupacis A, Boysen G, Connolly S, et al. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation : analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154: 1449-57. [Erratum, Arch Intern Med 1994;154:2254.] 52. Hart RG, Pearce LA, Rothbart RM, McAnulty JH, Asinger RW, Hal- perin JL. Stroke with intermittent atrial fibrillation : incidence and predic- tors during aspirin therapy. J Am Coll Cardiol 2000;35:183-7. 53. Cobbe SM, Rae AP, Poloniecki JD, et al. A randomized, placebo-con-  . . .
--3000,2,750,2045,64601